Insurer Elevance Seeks Recalculated Medicare Star Rating in Lawsuit

Elevance Health Inc. (NYSE: ELV ) has sued the U.S. Department of Health and Human Services (HHS) and the Centers for Medicare & Medicaid Services (CMS), alleging the agencies unlawfully applied different standards to Medicare Advantage insurers when calculating 2026 Star Ratings. The insurer argues CMS recalculated a competitor’s ratings after a court ruling but refused to extend the same treatment to Elevance, costing the company an estimated $115 million in 2027 quality bonus payments. Read Also: Elevance Health Stock Sinks After CMS Freezes Medicare Advantage Enrollment Elevance Challenges CMS’s Star Ratings Decision In a complaint filed last week, Elevance contends CMS violated a core administrative law principle requiring similarly situated parties to receive the same treatment. The dispute centers on the Medicare Advantage Star Ratings program, which scores contract...